• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蓝光光动力疗法引起的严重皮肤反应。

Severe cutaneous reaction to photodynamic therapy with blue light.

作者信息

Moore Mary M, Reyna Cindy, Hope Richard H

机构信息

Department of Dermatology, Texas Tech University Health Sciences Center, Lubbock, TX, USA.

出版信息

J Drugs Dermatol. 2011 Sep;10(9):1057-8.

PMID:22052277
Abstract

Photodynamic therapy (PDT) has been considered a safe and efficacious treatment for actinic keratoses (AKs) of the scalp and face. The procedure involves exposing a patient to a blue light source 1-4 hours after application of photosensitizing aminolevulinic acid (ALA) at a dose of 10 J/cm2 for up to 1000 seconds.(1,2) We suggest that amount of exposure time and area of exposure should be stratified according to baseline photodamage.

摘要

光动力疗法(PDT)被认为是治疗头皮和面部光化性角化病(AKs)的一种安全有效的方法。该程序包括在以10 J/cm²的剂量应用光敏氨基乙酰丙酸(ALA)后1至4小时,将患者暴露于蓝光光源下长达1000秒。(1,2)我们建议,暴露时间和暴露面积应根据基线光损伤情况进行分层。

相似文献

1
Severe cutaneous reaction to photodynamic therapy with blue light.蓝光光动力疗法引起的严重皮肤反应。
J Drugs Dermatol. 2011 Sep;10(9):1057-8.
2
A multicenter, randomized, vehicle-controlled phase 2 study of blue light photodynamic therapy with aminolevulinic acid HCl 20% topical solution for the treatment of actinic keratoses on the upper extremities: the effect of occlusion during the drug incubation period.一项多中心、随机、赋形剂对照的2期研究,评估20%盐酸氨基酮戊酸局部溶液蓝光光动力疗法治疗上肢光化性角化病:药物孵育期封包的效果
J Drugs Dermatol. 2012 Dec;11(12):1483-9.
3
A randomized, blinded, bilateral intraindividual, vehicle-controlled trial of the use of photodynamic therapy with 5-aminolevulinic acid and blue light for the treatment of actinic keratoses of the upper extremities.一项使用5-氨基酮戊酸和蓝光进行光动力疗法治疗上肢光化性角化病的随机、双盲、双侧个体内、载体对照试验。
J Drugs Dermatol. 2011 Sep;10(9):1049-56.
4
Effect of retinoid pretreatment on outcomes of patients treated by photodynamic therapy for actinic keratosis of the hand and forearm.维甲酸预处理对光动力疗法治疗手部和前臂光化性角化病患者疗效的影响。
J Drugs Dermatol. 2011 Oct;10(10):1124-32.
5
The impact of different fluence rates on pain and clinical outcome in patients with actinic keratoses treated with photodynamic therapy.不同辐照剂量对光动力疗法治疗光化性角化病患者疼痛和临床疗效的影响。
Photodermatol Photoimmunol Photomed. 2011 Aug;27(4):181-5. doi: 10.1111/j.1600-0781.2011.00595.x.
6
Topical photodynamic therapy for dermatologic disorders: results and complications.用于皮肤病的局部光动力疗法:结果与并发症
J Drugs Dermatol. 2007 Dec;6(12):1197-202.
7
Treatment of facial actinic keratoses with aminolevulinic acid photodynamic therapy (ALA-PDT) or ingenol mebutate 0.015% gel with and without prior treatment with ALA-PDT.用氨基酮戊酸光动力疗法(ALA-PDT)或0.015%鬼臼毒素凝胶治疗面部光化性角化病,以及是否在ALA-PDT治疗之前进行治疗。
J Drugs Dermatol. 2014 Nov;13(11):1353-6.
8
Pain during topical photodynamic therapy of actinic keratoses with 5-aminolevulinic acid and red light source: randomized controlled trial.光动力疗法治疗光化性角化病时使用 5-氨基酮戊酸和红光引起的疼痛:随机对照试验。
Photodermatol Photoimmunol Photomed. 2013 Aug;29(4):173-81. doi: 10.1111/phpp.12044.
9
Photodynamic therapy with aminolevulinic acid topical solution and visible blue light in the treatment of multiple actinic keratoses of the face and scalp: investigator-blinded, phase 3, multicenter trials.外用氨基酮戊酸溶液联合可见蓝光光动力疗法治疗面部和头皮多发性光化性角化病:研究者设盲的3期多中心试验。
Arch Dermatol. 2004 Jan;140(1):41-6. doi: 10.1001/archderm.140.1.41.
10
Evaluation of the chemopreventative effects of ALA PDT in patients with multiple actinic keratoses and a history of skin cancer.评估ALA光动力疗法对患有多发性光化性角化病且有皮肤癌病史患者的化学预防效果。
J Drugs Dermatol. 2012 May;11(5):593-7.